About
About Us
Management Team
Board of Directors
Pipeline
Overview
Hepatitis C Virus
Hepatitis B Virus
Respiratory Syncytial Virus
SARS-CoV-2
Human Metapneumovirus
Science
Overview
Publications
Patients
Overview
Clinical Trials
Resources
Careers
Join Us
Culture
Core Values
Testimonials
Benefits
Collaborations
Partnering
Out-Licensing
Investors
Overview
Press Releases
Events & Presentations
Stock Information
Financials
Corporate Governance
Investor Resources
Contact Us
About
About
About Us
Management Team
Board of Directors
Pipeline
Overview
Hepatitis C Virus
Hepatitis B Virus
Respiratory Syncytial Virus
SARS-CoV-2
Human Metapneumovirus
Science
Overview
Publications
Patients
Overview
Clinical Trials
Resources
Careers
Join Us
Culture
Core Values
Testimonials
Benefits
Collaborations
Partnering
Out-Licensing
Investors
Overview
Press Releases
Events & Presentations
Stock Information
Financials
Corporate Governance
Investor Resources
Contact Us
1999
Yat Sun Or, Ph.D. Joins Enanta Pharmaceuticals as Chief Scientific Officer
MENU
About
About Us
Management Team
Board of Directors
Pipeline
Overview
Hepatitis C Virus
Hepatitis B Virus
Respiratory Syncytial Virus
SARS-CoV-2
Human Metapneumovirus
Science
Overview
Publications
Patients
Overview
Clinical Trials
Resources
Careers
Join Us
Culture
Core Values
Testimonials
Benefits
Collaborations
Partnering
Out-Licensing
Investors
Overview
Press Releases
Events & Presentations
Stock Information
Financials
Corporate Governance
Investor Resources
Contact Us